Chapter 29 - The Breakthrough
The third year of my tenure as Chairwoman brought a monumental validation of my new corporate strategy. The Lily Vale Fellowship wasn't just generating good PR; it was generating revolutionary science.
Sarah Jenkins, the young MIT prodigy I had funded during my first year, had spent the last twenty-four months utilizing our state-of-the-art labs and manufacturing resources. On a brisk November morning, she requested an emergency meeting with the executive board.
I sat at the head of the boardroom table, surrounded by my top executives. Sarah stood at the front of the room, looking significantly more confident than she had during her initial interview. She didn't have blueprints this time; she had a physical prototype.
"Ladies and gentlemen," Sarah began, clicking a remote to illuminate the massive digital screen behind her. "Two years ago, Chairwoman Vale gave me the resources to pursue synthetic cellular regeneration. Today, I am proud to present the Vale-S1 Stent."
She held up a small, intricate mesh tube.
"This is not a traditional metal or plastic stent," Sarah explained, her voice steady and professional. "This is printed from a bio-compatible synthetic polymer that actively encourages the regeneration of arterial walls. Within six months of implantation, the stent dissolves entirely, leaving behind a perfectly healed, naturally functioning artery. It completely eliminates the risk of long-term thrombosis and rejection."
The room fell into a stunned, absolute silence. The chief medical officer, a veteran surgeon with thirty years of experience, took off his glasses, staring at the screen in pure disbelief.
"Sarah," he breathed. "If the clinical trials support this... this will render traditional stents obsolete. This is a multi-billion dollar patent. This will save millions of lives."
"The preliminary animal trials are complete and flawless," Sarah smiled, looking directly at me. "We are ready for human trials."
May you like
I felt a rush of overwhelming pride. Grant had spent millions on vanity projects and corporate espionage to maintain his status. I had invested in the brilliance of a young woman, and she had just handed Vale Medical the greatest medical breakthrough of the decade.
"Initiate the FDA fast-track protocol immediately," I commanded, standing up from my chair. "Sarah, you will be named as the lead inventor on the patent, and you will receive full royalties. Congratulations. You just changed the world."
